SCOPUS 정보 검색 플랫폼

Annals of Hematology

Volumn 84, Issue 10, 2005, Pages 692-693

Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia [3]

(6) Penack, Olaf a Sotlar, Karl b Noack, Frank c Horny, Hans Peter c Thiel, Eckhard a Notter, Michael a

a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN (Germany)

b UNIVERSITY OF TÜBINGEN (Germany)

c UNIVERSITY OF LÜBECK (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CLADRIBINE; COTRIMOXAZOLE; IMATINIB; PEGINTERFERON; TRYPTASE; TYROSINE KINASE RECEPTOR;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; BONE LESION; BONE MARROW BIOPSY; CANCER SURVIVAL; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DISEASE SEVERITY; DNA DETERMINATION; DRUG EFFICACY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; INFECTION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MALE; MAST CELL LEUKEMIA; OSTEOSCLEROSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CLADRIBINE; HUMANS; LEUKEMIA, MAST-CELL; LEUKEMIA, SUBLEUKEMIC; MALE;

EID: 27644454273 PISSN: 09395555 EISSN: None Source Type: Journal
DOI: 10.1007/s00277-005-1057-x Document Type: Article

Times cited : (17)

References (7)

1
- 0345167915
- Cladribine therapy for systemic mastocytosis
- 10.1182/blood-2003-05-1699
- Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, van't Wout JW, Verhoef G, Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R (2003) Cladribine therapy for systemic mastocytosis. Blood 102:4270-4276 10.1182/blood-2003-05-1699
- (2003) Blood , vol.102 , pp. 4270-4276
- Kluin-Nelemans, H.C.¹ Oldhoff, J.M.² Van Doormaal, J.J.³ van't Wout, J.W.⁴ Verhoef, G.⁵ Gerrits, W.B.⁶ van Dobbenburgh, O.A.⁷ Pasmans, S.G.⁸ Fijnheer, R.⁹

2
- 0036493872
- The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
- 10.1182/blood.V99.5.1741
- Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99:1741-1744 10.1182/blood.V99.5.1741
- (2002) Blood , vol.99 , pp. 1741-1744
- Ma, Y.¹ Zeng, S.² Metcalfe, D.D.³ Akin, C.⁴ Dimitrijevic, S.⁵ Butterfield, J.H.⁶ McMahon, G.⁷ Longley, B.J.⁸

3
- 0041656424
- Imatinib for systemic mast-cell disease
- 10.1016/S0140-6736(03)14115-3
- Pardanani A, Elliott M, Reeder T, Li CY, Baxter EJ, Cross NC, Tefferi A (2003) Imatinib for systemic mast-cell disease. Lancet 362:535-536 10.1016/S0140-6736(03)14115-3
- (2003) Lancet , vol.362 , pp. 535-536
- Pardanani, A.¹ Elliott, M.² Reeder, T.³ Li, C.Y.⁴ Baxter, E.J.⁵ Cross, N.C.⁶ Tefferi, A.⁷

4
- 0344741334
- Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine
- 10.1016/S0145-2126(03)00185-1
- Pardanani A, Hoffbrand AV, Butterfield JH, Tefferi A (2004) Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine. Leuk Res 28:127-131 10.1016/S0145-2126(03)00185-1
- (2004) Leuk. Res. , vol.28 , pp. 127-131
- Pardanani, A.¹ Hoffbrand, A.V.² Butterfield, J.H.³ Tefferi, A.⁴

5
- 0035945661
- Treatment of systemic mast-cell disease with cladribine
- 10.1056/NEJM200101253440415
- Tefferi A, Li CY, Butterfield JH, Hoagland HC (2001) Treatment of systemic mast-cell disease with cladribine. N Engl J Med 344:307-309 10.1056/NEJM200101253440415
- (2001) N. Engl. J. Med. , vol.344 , pp. 307-309
- Tefferi, A.¹ Li, C.Y.² Butterfield, J.H.³ Hoagland, H.C.⁴

6
- 0041411106
- Diagnosis and treatment of systemic mastocytosis: State of the art
- 10.1046/j.1365-2141.2003.04575.x
- Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:695-717 10.1046/ j.1365-2141.2003.04575.x
- (2003) Br. J. Haematol. , vol.122 , pp. 695-717
- Valent, P.¹ Akin, C.² Sperr, W.R.³ Horny, H.P.⁴ Arock, M.⁵ Lechner, K.⁶ Bennett, J.M.⁷ Metcalfe, D.D.⁸

7
- 0003551212
- Pathology and genetics of tumours of haemopoietic and lymphoid tissues
- World Health Organization Classification of Tumours. Jaffe ES, Harris NL, Stein H, Vardiman JW IARC, Lyon
- World Health Organization Classification of Tumours. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haemopoietic and lymphoid tissues. IARC, Lyon, pp 291-302
- (2001) , pp. 291-302

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.